In the News

Aster Insights Names Dr. Anand Shah as Chief Executive Officer

Aster Insights has announced the appointment of Dr. Anand Shah as chief executive officer, effective immediately. He succeeds Jim Gabriele, who has stepped down from his position. Gabriele and Shah have collaborated closely on a number of strategic, operational, and business development initiatives over the...

Clinical ink Announces New Continuous Glucose Monitoring Solution

Clinical Ink, a global life science technology company, now offers continuous glucose monitoring (CGM) within its integrated digital biomarker solution. The new modules enable remote collection, central storage, and analysis of sensor data from commercially available devices for use in diabetes clinical trials. The solution...

RCT-DUPLICATE Findings Demonstrate Capability of Real-World Evidence Studies to Reach Conclusions Similar to Randomized Clinical Trials

Real-world evidence (RWE) technology and analytics company Aetion has announced the culmination of the RCT-DUPLICATE demonstration project, with complete findings published in The Journal of the American Medical Association (JAMA). This three-year initiative tested whether researchers asking clinical questions in real-world data (RWD)—data from patients’...

Inside the new world of healthcare data

In a recent episode of the PharmaPhorum podcast, Evidation co-CEO and Executive Chair of the Board Deborah Kilpatrick discussed healthcare data collection in 2023 and how it intersects with stakeholders across the ecosystem, from tech and pharma companies to research participants. The discussion began with data...

Replica Analytics unveils Replica Synthesis 3.0

Replica Analytics, an Aetion company, has released Replica Synthesis 3.0, its privacy- and utility-preserving synthetic data generation software that has been updated with an enhanced user experience. This makes it easier for analysts to train generative models and evaluate their utility and privacy. The company...

M2GEN Rebrands to Aster Insights

Bioinformatics company M2GEN has announced that it is rebranding, changing its name to Aster Insights. As the nexus between patients, researchers, and the life sciences industry, the company’s unique clinical and molecular dataset has enabled new insights for researchers and accelerated target identification and drug discovery....

Through reverse auctions, Minnesota pushes for PBM savings and price transparency

Truveris has helped the State of Minnesota save more than $28 million in pharmacy benefits expenses over the next two years. Using the company’s technology, the state was able to evaluate bids from competing pharmacy benefit managers (PBMs). Truveris’ technology allows health plan sponsors to conduct...